Jiang, Yiyue
Zhang, Zheng
Ren, Kangkang
Zhou, Shujuan
Qiao, Yang
Huang, Weilu
Zhang, Nanyang
Xu, Hanyan
Xu, Xinping
Wen, Bing
Zhang, Wei
Yin, Lu
Funding for this research was provided by:
Li Ka Shing Foundation (1210669001)
National Natural Science Foundation of China (32350610250)
Two-thousand Talent program of Jiangxi Province, China (jxsq2020101064)
Article History
Received: 17 February 2025
Accepted: 22 May 2025
First Online: 3 June 2025
Declarations
:
: Ethical approval for the collection and utilization of human samples was granted by the Medical Ethics Committee of the First Affiliated Hospital of Nanchang University. The collection and utilization of human third molars were approved on November 6th, 2023, under the project titled “Cell size-based microfluidic sorting of mesenchymal stem cell subpopulations with distinct mechanisms of action for cartilage repair” (Approval number: (2023) CDYFYYLK (11 − 002)). Additionally, the collection and utilization of human peripheral blood were approved on October 15th, 2024, under the project titled “The efficacy and mechanism of co-transplantation of microfluidic-selectively expanded distal airway stem cell and mesenchymal stem cell subpopulations for lung repair” (Approval number: (2024) CDYFYYLK (10–035)). All donors provided written informed consent for participation in the study and the use of samples.
: Not applicable.
: The authors declare no competing interests.